PMAM
DMTK

Picton Mahoney Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Picton Mahoney Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,660
Closed -$69K – 925
2022
Q1 		$69K Sell
4,660
-10,180
-69% -$136K ﹤0.01% 696
2021
Q4 		$235K Sell
14,840
-5,144
-26% -$124K 0.01% 686
2021
Q3 		$641K Hold
19,984
– – 0.02% 577
2021
Q2 		$832K Buy
+19,984
New +$821K 0.02% 578

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return

Picton Mahoney Asset Management's DMTK Position: Q2 2022 in Review

Picton Mahoney Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 4,660 shares — an estimated $69K sold.

Picton Mahoney Asset Management first reported a position in DMTK in Q2 2021 and held it in 4 quarters. The position peaked at $832K in Q2 2021. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • Picton Mahoney Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 4,660 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $69K.
  • Picton Mahoney Asset Management first reported a position in DermTech, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Picton Mahoney Asset Management's DermTech, Inc. Common Stock position peaked at $832K in Q2 2021.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.